English | Español

Astellas Pharma Us, Inc.
Carol Ostrow | Dec 3, 2017

Astellas will present AML findings at American Society of Hematology conference
Carrie Bradon | Dec 1, 2017

Astellas study shows women with overactive bladder symptoms use unconventional methods
Carrie Bradon | Nov 25, 2017

Astellas Oncology names C3 Prize winners
Marian Johns | Nov 19, 2017

Astellas receives perfect score on Corporate Equality Index for fourth consecutive year
Marian Johns | Oct 22, 2017

FDA grants fast-track status to Astellas' acute myeloid leukemia drug
Marian Johns | Oct 19, 2017

Astellas Pharma, Seattle Genetics begin clinical trial for bladder cancer treatment
Robert Hadley | Jul 7, 2017

Astellas says gilteritinib may be long-sought treatment in certain acute myeloid leukemia cases
Robert Hadley | Jun 22, 2017

Phase 3 trial of Pfizer’s prostate cancer drug could yield results two years early

Trending
+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas
Patient Daily | Jul 25, 2025

Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval